Engineering a local microenvironment for pancreatic islet replacement
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Intraportal islet transplantation has emerged as a promising treatment for type 1 diabetes mellitus (T1DM). Nevertheless, long-term efficacy has been limited to a marginal number of patients. Outcomes have been restricted, in part, by challenges associated with the transplant site, poor vascularization, and disruption of the native islet architecture during the isolation process. Engineering a biomaterial platform that recapitulates critical components of the pancreatic environment can serve to address these hurdles. This review highlights the challenges and opportunities in engineering 3-D niches for islets, specifically: the importance of site selection; the application of scaffold functionalization to present bioactive motifs; and the development of technologies for enhancing implant nutritional profiles. The potential of these novel approaches to improve islet engraftment and duration of function is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918 · cited 1×
“b-Cell–ECM interactions also play a critical role in the activation of NF-kB signaling, a critical pro-inflammatory regulator [17].”
Improvement in outcomes of clinical islet transplantation: 1999–2010
Barton, F. B., Rickels, M. R., Alejandro, R., Hering, B. J., Wease, S., Naziruddin, B., Oberholzer, J., Odorico, J. S., Garfinkel, M. R., Levy, M., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0063 · Cited by 725 · cited 1×
“com elimination of hypoglycemia for multiple years, long-term (>5 years) insulin independence has been achieved in only a subset of patients [1].”
Martino, M. M., Tortelli, F., Mochizuki, M., Traub, S., Ben-David, D., Kuhn, G. A., Müller, R., Livne, E., Eming, S. A., & Hubbell, J. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002614 · Cited by 459
Pedraza, E., Coronel, M. M., Fraker, C. A., Ricordi, C., & Stabler, C. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113560109 · Cited by 399 · cited 1×
“Recently, our group reported on the development of a hydrolytically reactive, oxygen generating biomaterial, based on the encapsulation of solid calcium peroxide [43].”
Self-citationOptimal implantation site for pancreatic islet transplantation
Merani, S., Toso, C., Emamaullee, J., & Shapiro, A. M. J. (2008) · British Journal of Surgery · doi:10.1002/bjs.6391 · Cited by 257 · cited 1×
“reproducibility (for a more comprehensive review see [5]).”
Hypoxia-inducible factor-1α regulates β cell function in mouse and human islets
Cheng, K., Ho, K., Stokes, R., Scott, C., Lau, S. M., Hawthorne, W. J., O’Connell, P. J., Loudovaris, T., Kay, T. W., Kulkarni, R. N., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci35846 · Cited by 230 · cited 1×
“In addition, HIF-1a has been shown to result in impairment of glucose responsiveness [38,39], which may further delay islet revascularization [40 ].”
Clinical and Experimental Pancreatic Islet Transplantation to Striated Muscle
Christoffersson, G., Henriksnäs, J., Johansson, L., Rolny, C., Ahlström, H., Caballero-Corbalan, J., Segersvärd, R., Permert, J., Korsgren, O., Carlsson, P.-O., et al. (2010) · Diabetes · doi:10.2337/db10-0205 · Cited by 167
The hypoxia response pathway and β ‐cell function
Cantley, J., Grey, S. T., Maxwell, P. H., & Withers, D. J. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01276.x · Cited by 119
Cited by
Engineered In Vitro Disease Models
Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H. J., MacQueen, L., Mahmoodian, R., et al. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040418 · Cited by 554
Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets
Vlahos, A. E., Cober, N., & Sefton, M. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619216114 · Cited by 132
“vascularity is poor (8), various strategies to vascularize the site are being explored (9, 10), e.”
BackgroundDecellularized scaffolds in regenerative medicine
Yu, Y., Alkhawaji, A., Ding, Y., & Mei, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10945 · Cited by 113
Immunotherapy via PD-L1–presenting biomaterials leads to long-term islet graft survival
Coronel, M. M., Martin, K. E., Hunckler, M. D., Barber, G., O’Neill, E. B., Medina, J. D., Opri, E., McClain, C. A., Batra, L., Weaver, J. D., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba5573 · Cited by 89
“The microgel platform was tested in the EFP site as opposed to the kidney capsule, for a more clinically relevant transplant site (26).”
MethodSelf-citationCoronel, M. M., Liang, J.-P., Li, Y., & Stabler, C. L. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.017 · Cited by 85
Self-citation
Metadata
- Authors
- Coronel, M. M., & Stabler, C. L.
- Venue
- Current Opinion in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 24
- Issue
- 5
- Pages
- 900-908
- ISSN
- 0958-1669 (ISSN-L)
- OpenAlex
- W2092316227
- Cited by
- 65
- References
- 8
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.